Randomized and Controlled Clinical Trial to Evaluate Bacterial Adhesion on Multi-Im® Transepithelial Components

Inclusion Criteria: * Indication of having to place at least three dental implants. * Plate index ≤ 20% and absence of evidence of active periodontal disease. * Bleeding index of adjacent teeth ≤ 30%. * Probing depth in adjacent teeth \<4 mm. * Not having used systemic antibiotics during the last 6 months. * Non smoker. * Possibility for observation during the treatment period. * Having signed the informed consent. Exclusion Criteria: * Suffering any alteration or serious hematologic disease. * Being undergoing or having received in the 30 days prior to inclusion: radiotherapy, chemotherapy or immunosuppressive treatments, systemic corticosteroids and/or anticoagulants. * Presence of malignant tumors, hemangiomas or angiomas in the area of implant placement. * Patients undergoing treatment with bisphosphonate drugs, both orally and intravenously. * Metabolic bone disease. * Diseases that affect the oral mucosa. * Diabetic patients. * Severe parafunctional habits and/or temporomandibular joint disorders. * Pregnant or lactating women. * Physical or mental inability to maintain a good oral hygiene. * Being participating in another study. * In general, any inability to participate in the study.